High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
- PMID: 32258207
- PMCID: PMC7111600
- DOI: 10.1093/ofid/ofaa102
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
Abstract
The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19.
Keywords: coronavirus disease 2019; high-dose intravenous immunoglobulin; immunomodulation.
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Figures
References
-
- Real-time updates: national outbreak map of new coronary virus pneumonia Available at: https://news.sina.cn/zt_d/yiqing0121. Accessed 12 March 2020.
-
- National Health Commission of the People’s Republic of China. Chinese recommendations for diagnosis and treatment of novel coronavirus (SARS-CoV2) infection (pilot 4th version). Available at: http://www.gov.cn/zhengce/zhengceku/2020-01/28/5472673/files/0f96c10cc09.... Accessed 12 March 2020.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical